Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
N4 Pharma ( (GB:N4P) ) has issued an update.
N4 Pharma plc announced that all resolutions were passed at its annual general meeting, including the re-election and election of directors and the appointment of a new auditor. This successful AGM reflects strong shareholder support and positions the company to continue its development efforts in the biotech industry.
More about N4 Pharma
N4 Pharma plc is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system designed to enhance advanced therapies for cancer and other diseases.
Average Trading Volume: 1,691,883
Technical Sentiment Signal: Sell
Current Market Cap: £5.71M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.